GT Biopharma Stock Forecast - Period Momentum Indicator
GTBP Stock | USD 3.05 0.14 4.39% |
GTBP Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast GT Biopharma stock prices and determine the direction of GT Biopharma's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of GT Biopharma's historical fundamentals, such as revenue growth or operating cash flow patterns. Although GT Biopharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of GT Biopharma's systematic risk associated with finding meaningful patterns of GT Biopharma fundamentals over time.
Check out Historical Fundamental Analysis of GT Biopharma to cross-verify your projections. GTBP |
Open Interest Against 2024-07-19 GTBP Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast GT Biopharma's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in GT Biopharma's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for GT Biopharma stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current GT Biopharma's open interest, investors have to compare it to GT Biopharma's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of GT Biopharma is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in GTBP. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Most investors in GT Biopharma cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the GT Biopharma's time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets GT Biopharma's price structures and extracts relationships that further increase the generated results' accuracy.
Momentum indicator evaluates the difference between todays closing price and the close price n periods ago. It is the velocity with which the price is rising or falling. It also reflects how aggressively the asset is purchased or sold by the public.Previous Period Momentum Indicator | Period Momentum Indicator | Trend |
(0.08) | (0.14) |
Check GT Biopharma Volatility | Backtest GT Biopharma | Information Ratio |
GT Biopharma Trading Date Momentum
On May 16 2024 GT Biopharma was traded for 3.05 at the closing time. The top price for the day was 3.05 and the lowest listed price was 3.05 . There was no trading activity during the period 0.0. Lack of trading volume on May 16, 2024 did not cause price change. The overall trading delta against the current closing price is 4.59% . |
Generally speaking extended values of the momentum indicator over time are good indicators of oversold or over brought conditions.
Compare GT Biopharma to competition |
Other Forecasting Options for GT Biopharma
For every potential investor in GTBP, whether a beginner or expert, GT Biopharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. GTBP Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in GTBP. Basic forecasting techniques help filter out the noise by identifying GT Biopharma's price trends.View GT Biopharma Related Equities
Risk & Return | Correlation |
GT Biopharma Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of GT Biopharma's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of GT Biopharma's current price.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
GT Biopharma Market Strength Events
Market strength indicators help investors to evaluate how GT Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading GT Biopharma shares will generate the highest return on investment. By undertsting and applying GT Biopharma stock market strength indicators, traders can identify GT Biopharma entry and exit signals to maximize returns.
Daily Balance Of Power | (9,223,372,036,855) | |||
Rate Of Daily Change | 0.96 | |||
Day Median Price | 3.05 | |||
Day Typical Price | 3.05 | |||
Price Action Indicator | (0.07) | |||
Period Momentum Indicator | (0.14) |
GT Biopharma Risk Indicators
The analysis of GT Biopharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in GT Biopharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting gtbp stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Mean Deviation | 4.28 | |||
Standard Deviation | 5.71 | |||
Variance | 32.61 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of GT Biopharma to cross-verify your projections. To learn how to invest in GTBP Stock, please use our How to Invest in GT Biopharma guide.Note that the GT Biopharma information on this page should be used as a complementary analysis to other GT Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for GTBP Stock analysis
When running GT Biopharma's price analysis, check to measure GT Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GT Biopharma is operating at the current time. Most of GT Biopharma's value examination focuses on studying past and present price action to predict the probability of GT Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GT Biopharma's price. Additionally, you may evaluate how the addition of GT Biopharma to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Commodity Directory Find actively traded commodities issued by global exchanges |
Is GT Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GT Biopharma. If investors know GTBP will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GT Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.58) | Return On Assets (0.55) | Return On Equity (0.79) |
The market value of GT Biopharma is measured differently than its book value, which is the value of GTBP that is recorded on the company's balance sheet. Investors also form their own opinion of GT Biopharma's value that differs from its market value or its book value, called intrinsic value, which is GT Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GT Biopharma's market value can be influenced by many factors that don't directly affect GT Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GT Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if GT Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GT Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.